CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI

    China SXT Pharmaceuticals, Inc. Announces Share

    TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today…

    Read More
    CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI

      CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI

      TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”),…

      Read More